These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35386180)

  • 41. Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension.
    Al-Samkari H; Nagalla S
    Platelets; 2022 Feb; 33(2):257-264. PubMed ID: 33586606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li C; Li X; Huang F; Yang J; Wu A; Wang L; Qin D; Zou W; Wu J
    Front Pharmacol; 2019; 10():829. PubMed ID: 31402863
    [No Abstract]   [Full Text] [Related]  

  • 43. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S; Terrault NA
    Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Romiplostim as a treatment for immune thrombocytopenia: a review.
    Chalmers S; Tarantino MD
    J Blood Med; 2015; 6():37-44. PubMed ID: 25632241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Review of Romiplostim Mechanism of Action and Clinical Applicability.
    Bussel JB; Soff G; Balduzzi A; Cooper N; Lawrence T; Semple JW
    Drug Des Devel Ther; 2021; 15():2243-2268. PubMed ID: 34079225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Efficacy and Safety of Thrombopoietin Receptor Agonists in Adults With Thrombocytopenia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trial.
    Deng J; Hu H; Huang F; Huang C; Huang Q; Wang L; Wu A; Yang J; Qin D; Zou W; Wu J
    Front Pharmacol; 2021; 12():704093. PubMed ID: 34393785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials.
    Shen N; Qiao J; Jiang Y; Yin H; Li M; Zhu S; Li J
    Exp Ther Med; 2023 Aug; 26(2):393. PubMed ID: 37456173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avatrombopag for the salvage treatment of platelet transfusion refractoriness.
    Qin Y; Wang Y; Zhang Y; Jiao Y; Ye J
    Ther Adv Hematol; 2024; 15():20406207241237606. PubMed ID: 38481948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Terrault N; Chen YC; Izumi N; Kayali Z; Mitrut P; Tak WY; Allen LF; Hassanein T
    Gastroenterology; 2018 Sep; 155(3):705-718. PubMed ID: 29778606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.
    Wojciechowski P; Wilson K; Nazir J; Pustułka I; Tytuła A; Smela B; Pochopien M; Vredenburg M; McCrae KR; Jurczak W
    Adv Ther; 2021 Jun; 38(6):3113-3128. PubMed ID: 33934279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
    Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z
    Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.
    Ayad N; Grace RF; Al-Samkari H
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29447. PubMed ID: 34962697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.
    Bussel JB; Kuter DJ; Aledort LM; Kessler CM; Cuker A; Pendergrass KB; Tang S; McIntosh J
    Blood; 2014 Jun; 123(25):3887-94. PubMed ID: 24802775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia.
    Eguchi Y; Takahashi H; Mappa S; Santagostino E
    Hepatol Res; 2022 Apr; 52(4):371-380. PubMed ID: 35134259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.
    Iino M; Sakamoto Y; Sato T
    Int J Hematol; 2020 Aug; 112(2):159-168. PubMed ID: 32476083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.
    Zeng Y; Duan X; Xu J; Ni X
    Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD008235. PubMed ID: 21735426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review.
    Birocchi S; Podda GM; Manzoni M; Casazza G; Cattaneo M
    Platelets; 2021 Feb; 32(2):216-226. PubMed ID: 32281449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Study.
    Liu Y; Zhang HX; Su J; Geng QC; Lin X; Feng CX
    Acta Haematol; 2023; 146(3):173-184. PubMed ID: 36572014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Avatrombopag-induced lactic acidosis in a patient with severe thrombocytopenia.
    Addiego AM; Razi S; Li H
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38061849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.